Clostridioides difficile infection in intestinal transplantation: The quest for better outcomes continues

Carlos A Gomez¹, Diana F Florescu^{1

2}

Affiliations

¹ Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
² Transplant Surgery Division, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Editorial

Carlos A Gomez et al. Transpl Infect Dis. 2023 Feb.

. 2023 Feb;25(1):e13952.

doi: 10.1111/tid.13952. Epub 2023 Jan 10.

Carlos A Gomez¹, Diana F Florescu^{1

2}

¹ Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
² Transplant Surgery Division, University of Nebraska Medical Center, Omaha, Nebraska, USA.

No abstract available

References

1. Mullane KM, Dubberke ER, AST ID Community of Practice. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: guidelines from the American Society of Transplantation Community of Practice. Clin Transplant. 2019;33(9):e13564.
1. Guzman L, Qiu F, Kalil AC, Mercer DF, Langnas A, Florescu DF. Risk factors for Clostridium difficile infection in intestinal transplant recipients during the first year post-transplant. Transpl Infect Dis. 2018;20(2):e12858.
1. Goldenberg V, Berbel A, Camargo JF, Simkins J. Clostridium difficile infection in intestinal transplant recipients. Transpl Int. 2018;31(1):116-117.
1. Pascal V, Pozuelo M, Borruel N, et al. A microbial signature for Crohn's disease. Gut. 2017;66(5):813-822.
1. Hartman AL, Lough DM, Barupal DK, et al. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci USA. 2009;106(40):17187-17192.